Medicine
Cysto-Conray II 43000 mg/250 mL injection
Cysto-Conray II 43000 mg/250 mL injection is a prescription medicine containing Iothalamate for ureteral use, marketed by Liebel-Flarsheim, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). If this occurs, the containers should be…
Key facts
- Active ingredient (INN)
- Iothalamate
- Brand
- Cysto-Conray II
- Strength
- 43000 mg/250 mL
- Dosage form
- Injection
- Route
- Ureteral
- Packs
- 12 bottles of 250 mL
- Marketing authorisation holder
- Liebel-Flarsheim
- Manufacturer
- Liebel-Flarsheim
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). If this occurs, the containers should be brought to room temperature. This product is sensitive to light and must be protected from strong daylight or direct exposure to the sun.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V08AA04 Iothalamate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 October 2010
- Identifiers
- DailyMed set ID 8841ab4d-674d-4beb-88a5-13e35f6005ccNDC 0019-0862Application NDA017057
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 bottle, glass in 1 box / 250 mL in 1 bottle, glass | 0019-0862-50 | Liebel-Flarsheim | 8 October 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 16 August 1962 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Iothalamate is a radiographic contrast agent indicated in retrograde cystography and cystourethrography. It is available as injection for ureteral use. MedsAcross supplies Iothalamate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IothalamateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cysto-Conray II prescribing information (Liebel-Flarsheim) · U.S. National Library of Medicine, DailyMed
Need Cysto-Conray II 43000 mg/250 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.